Filing Details
- Accession Number:
- 0001415889-25-008452
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-18 17:20:05
- Reporting Period:
- 2025-03-14
- Filing Date:
- 2025-03-18
- Accepted Time:
- 2025-03-18 17:20:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1323212 | Eric Pauwels | C/O Ptc Therapeutics, Inc. 500 Warren Corporate Center Drive Warren NJ 07059 | Chief Business Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-03-14 | 4,458 | $55.19 | 79,402 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-17 | 2,037 | $55.24 | 77,365 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-17 | 1,085 | $56.62 | 76,280 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-17 | 3,340 | $57.67 | 72,940 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-17 | 300 | $58.31 | 72,640 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 13, 2024.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.00 to $55.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.00 to $55.98 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.20 to $57.14 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $57.30 to $58.26 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.30 to $58.31 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
